Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Abrahamowicz

Showing results (111-120 of 305) with videos related to

Pageof 31
Sort By:
BMJ (Clinical Research Ed.)|February 24, 2017
Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing systemJenna Wong, Aude Motulsky, Michal Abrahamowicz, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Longitudinal patterns of new Benzodiazepine use in the elderlyGillian Bartlett, Michal Abrahamowicz, Robyn Tamblyn, et al.
Arthritis and Rheumatism|October 7, 2005
Maintenance of exercise in women with fibromyalgiaPatricia L Dobkin, Michal Abrahamowicz, Mary-Ann Fitzcharles, et al.
International Psychogeriatrics|April 28, 2006
Classification of patterns of delirium severity scores over time in an elderly populationMarie-Pierre Sylvestre, Jane McCusker, Martin Cole, et al.
Journal of Clinical Epidemiology|December 17, 2008
Flexible statistical models provided new insights into the role of quantitative prognostic factors for mortality in gastric cancerChristine Binquet, Michal Abrahamowicz, Karine Astruc, et al.
Arthritis and Rheumatism|August 1, 2008
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritisDiane Lacaille, Daphne P Guh, Michal Abrahamowicz, et al.
Journal of the American Heart Association|July 8, 2023
Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril-Valsartan for the Treatment of Heart FailureZahra N Sohani, Hassan Behlouli, Cristiano Soares de Moura, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2013
Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal studyJulie Bruneau, Geng Zang, Michal Abrahamowicz, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2015
Diagnostic accuracy of algorithms to identify hepatitis C status, AIDS status, alcohol consumption and illicit drug use among patients living with HIV in an administrative healthcare databaseMadeleine Durand, Yishu Wang, François Venne, et al.
Biometrical Journal. Biometrische Zeitschrift|February 27, 2023
Comparison of cohort and nested case-control designs for estimating the effect of time-varying drug exposure on the risk of adverse event in the presence of tiesLiliane Manitchoko, Michal Abrahamowicz, Pascale Tubert-Bitter, et al.
Pageof 31

Showing results (111-120 of 305) with videos related to

Sort By:
Pageof 31
BMJ (Clinical Research Ed.)|February 24, 2017
Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing systemJenna Wong, Aude Motulsky, Michal Abrahamowicz, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Longitudinal patterns of new Benzodiazepine use in the elderlyGillian Bartlett, Michal Abrahamowicz, Robyn Tamblyn, et al.
Arthritis and Rheumatism|October 7, 2005
Maintenance of exercise in women with fibromyalgiaPatricia L Dobkin, Michal Abrahamowicz, Mary-Ann Fitzcharles, et al.
International Psychogeriatrics|April 28, 2006
Classification of patterns of delirium severity scores over time in an elderly populationMarie-Pierre Sylvestre, Jane McCusker, Martin Cole, et al.
Journal of Clinical Epidemiology|December 17, 2008
Flexible statistical models provided new insights into the role of quantitative prognostic factors for mortality in gastric cancerChristine Binquet, Michal Abrahamowicz, Karine Astruc, et al.
Arthritis and Rheumatism|August 1, 2008
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritisDiane Lacaille, Daphne P Guh, Michal Abrahamowicz, et al.
Journal of the American Heart Association|July 8, 2023
Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril-Valsartan for the Treatment of Heart FailureZahra N Sohani, Hassan Behlouli, Cristiano Soares de Moura, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2013
Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal studyJulie Bruneau, Geng Zang, Michal Abrahamowicz, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2015
Diagnostic accuracy of algorithms to identify hepatitis C status, AIDS status, alcohol consumption and illicit drug use among patients living with HIV in an administrative healthcare databaseMadeleine Durand, Yishu Wang, François Venne, et al.
Biometrical Journal. Biometrische Zeitschrift|February 27, 2023
Comparison of cohort and nested case-control designs for estimating the effect of time-varying drug exposure on the risk of adverse event in the presence of tiesLiliane Manitchoko, Michal Abrahamowicz, Pascale Tubert-Bitter, et al.
Pageof 31